High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation.
about
CMV in Hematopoietic Stem Cell TransplantationHow I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipientsEmerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management.Approach to drug-resistant cytomegalovirus in transplant recipients.Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with CytomegalovirusImmunotherapy for opportunistic infections: Current status and future perspectives.Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.Diagnosis of Cytomegalovirus Infection during Exacerbation of Ulcerative Colitis.Toxic megacolon and interstitial pneumonia caused by cytomegalovirus infection in a pediatric patient with acute lymphoblastic leukemia receiving chemotherapy.The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus.Cytomegalovirus antiviral drug resistance: future prospects for prevention, detection and management.Cytomegalovirus resistance in CD34+ -selected hematopoietic cell transplant recipients.Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication
P2860
Q26740385-1D6DF016-03D4-461E-89D4-DA0C4E8217BDQ28069489-A790F06A-47DA-4493-9102-F947A55BE851Q34342514-5A8D5B1D-5B2A-42BD-A2D6-1527AA2F9790Q35908691-D79EF25F-16A0-47AE-BDA2-3237DDCA42A2Q37242897-6C42D1A4-BCBD-4055-83E7-F0F6025BA128Q37509216-307F4B02-E51E-4D21-8F28-F3E18F9D68C4Q38617612-64C4A589-D8E6-4180-A403-58BEAA8B2588Q38779846-5B3B4805-70E5-4210-BBAC-6918221555F8Q40041684-379B265C-E0C5-49B1-A837-F2621FDD618AQ40370786-D680D2E9-7D73-45D4-9E82-1A9A17A903AAQ41657330-C80C7DE5-C689-4EA5-998F-910B197CB213Q47446877-78FC0ECC-9DAE-4E07-BFBF-20DA91FDD6EAQ48365609-8BE89350-7228-4613-9A1D-2C71C4C10BA9Q52640678-6569F00B-F8DA-4259-886C-05D4DCF09113Q52728829-3C7804B0-A1C0-4749-91F8-D8C2414D9DFBQ56374730-2ED8534A-8860-477C-97EC-679D787F5F53
P2860
High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
High rate of cytomegalovirus d ...... cal stem cell transplantation.
@en
High rate of cytomegalovirus d ...... cal stem cell transplantation.
@nl
type
label
High rate of cytomegalovirus d ...... cal stem cell transplantation.
@en
High rate of cytomegalovirus d ...... cal stem cell transplantation.
@nl
prefLabel
High rate of cytomegalovirus d ...... cal stem cell transplantation.
@en
High rate of cytomegalovirus d ...... cal stem cell transplantation.
@nl
P2093
P2860
P356
P1476
High rate of cytomegalovirus d ...... cal stem cell transplantation.
@en
P2093
Dana G Wolf
Einat Shmueli
Igor B Resnick
Michael Y Shapira
Orit Caplan
Tali Bdolah-Abram
P2860
P304
P356
10.1093/INFDIS/JIT475
P407
P577
2013-08-27T00:00:00Z